Le Lézard
Classified in: Science and technology
Subject: PLW

Conektto announces award of USPTOs issue of patent for API Development with Groundbreaking GenAI based Automated Artifact Generation System


In an innovative leap forward for the world of software development, Conektto is proud to announce the issue of patent by USPTO ? an automated system designed to transform the generation of artifacts from API specifications. Utilizing cutting-edge natural language processing (NLP) and advanced computational techniques like GenAI, Conektto's platform promises to streamline the API development process, significantly reducing the time and effort required to create, test, and deploy APIs.

DUBLIN and HYDERABAD, India, March 6, 2024 /PRNewswire-PRWeb/ -- Traditionally, the creation of artifacts such as webservice code, test data, and monitoring programs for API development has been a manual, time-consuming, and error-prone process. Recognizing the need for efficiency and accuracy in this critical area, Conektto's innovative solution automates the analysis of API specifications. By scoring, ranking, and mapping the dependencies of API elements, the system generates a comprehensive metamodel that accurately represents the functional and operational aspects of an API.

The issue of this patent from USPTO marks a milestone and significant validation in Conektto's commitment to innovation and excellence in the field of software development.

This metamodel serves as the foundation for the automatic generation of a wide array of code components, including but not limited to, deployable code, virtual services, and functional tests. As a result, developers can now focus on higher-level tasks and innovation, while the system handles the intricate details of API artifact creation.

By leveraging GenAI, Conektto's platform automatically generates and validates a wide range of use cases for each API, significantly enhancing the testing phase. This ensures that APIs are not just theoretically sound but are also proven to work seamlessly in diverse and complex operational environments, thereby reducing time to market and increasing reliability.

A key feature of Conektto's technology is its user-friendly interface, which allows for the creation of new APIs by matching database entities to API elements seamlessly. This not only facilitates the rapid development of APIs but also ensures consistency and compatibility across different systems and databases.

"Our mission at Conektto has always been to empower developers by simplifying the complexities of API development," said Amol Dewhare, CEO of Conektto. "With this new automated artifact generation system, we are taking a significant step towards realizing this vision. By automating what used to be a laborious process, we are not only boosting productivity but also enhancing the quality and reliability of API-driven applications."

Conektto's platform system integrates Generative AI (GenAI) techniques to validate use cases, ensuring that API artifacts not only meet technical specifications but also align perfectly with real-world application scenarios. This approach guarantees that generated APIs are robust, secure, scalable, and tailored to address specific business needs effectively.

Media Contact

Amol Dewhare, Conektto, 1 9252168320, [email protected]www.conektto.io

LinkedIn

SOURCE Conektto


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: